Skip to content

Occurrence of PXG which is the type of secondary Glaucoma in rural population.

Prevalence of pseudoexfoliation glaucoma (PXG) in pseudoexfoliation (PXF) cases in the rural area of South Gujarat.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/05/033401
Enrollment
100
Registered
2021-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H408- Other glaucoma

Interventions

None listed

Sponsors

Divyajyoti Trust
Lead Sponsor
Divyajyoti Trust
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All patients Age with the less than 40 years Patients with PXF. This Patient (also referred as Subject in this document) Information and Consent Form explains the research study. Knowing what is involved will help you decide whether you want to take part in the research. Please read this information carefully and ask questions about anything that you do not understand or want to know more about. Your study doctor or study nurse will answer all questions you have about the information in this form. Before you make your decision about whether to participate in this research study, a member of the research team will be available so that you can ask any questions you have about the research study. You should sign and date the Subject Consent section only if you agree to participate in the research study and only after you have had a chance to ask your questions and have received satisfactory answers.

Exclusion criteria

Exclusion criteria: Previous uveitis Pigment dispersion syndrome Traumatic angle recession. Patients with any other eye disease affecting intraocular pressure or visual field Patients with secondary glaucoma other than PXG.

Design outcomes

Primary

MeasureTime frame
Prevalence of pseudoexfoliation glaucoma (PXG) in pseudoexfoliation (PXF) cases in the rural area of South Gujarat.Timepoint: Outcomes will be accessed after 6 to 8 months.

Secondary

MeasureTime frame
To access number of patients who develop PXG.Timepoint: Outcomes will be accessed after 6 to 8 months.

Countries

India

Contacts

Public ContactDr Uday Gajiwala

Divyajyoti Trust

mansikaria13@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026